Ampicillin: Potent Broad-Spectrum Antibiotic Treatment
Ampicillin
| Product dosage: 250mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $4.00 | $40.00 (0%) | 🛒 Add to cart |
| 20 | $2.25 | $80.00 $45.00 (44%) | 🛒 Add to cart |
| 30 | $1.67 | $120.00 $50.00 (58%) | 🛒 Add to cart |
| 60 | $0.92 | $240.00 $55.00 (77%) | 🛒 Add to cart |
| 90 | $0.67 | $360.00 $60.00 (83%) | 🛒 Add to cart |
| 120 | $0.54 | $480.00 $65.00 (86%) | 🛒 Add to cart |
| 180 | $0.39 | $720.00 $70.00 (90%) | 🛒 Add to cart |
| 270 | $0.28 | $1080.00 $75.00 (93%) | 🛒 Add to cart |
| 360 | $0.24
Best per pill | $1440.00 $85.00 (94%) | 🛒 Add to cart |
| Product dosage: 500mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $4.50 | $45.00 (0%) | 🛒 Add to cart |
| 20 | $2.50 | $90.00 $50.00 (44%) | 🛒 Add to cart |
| 30 | $1.83 | $135.00 $55.00 (59%) | 🛒 Add to cart |
| 60 | $1.00 | $270.00 $60.00 (78%) | 🛒 Add to cart |
| 90 | $0.72 | $405.00 $65.00 (84%) | 🛒 Add to cart |
| 120 | $0.58 | $540.00 $70.00 (87%) | 🛒 Add to cart |
| 180 | $0.50 | $810.00 $90.00 (89%) | 🛒 Add to cart |
| 270 | $0.41 | $1215.00 $110.00 (91%) | 🛒 Add to cart |
| 360 | $0.39
Best per pill | $1620.00 $140.00 (91%) | 🛒 Add to cart |
Synonyms | |||
Ampicillin is a beta-lactam antibiotic belonging to the aminopenicillin class, widely recognized for its bactericidal activity against a range of Gram-positive and Gram-negative pathogens. It functions by inhibiting bacterial cell wall synthesis, leading to osmotic instability and cell lysis. This semi-synthetic penicillin derivative is indicated for the treatment of various bacterial infections, including respiratory tract infections, urinary tract infections, meningitis, and gastrointestinal infections caused by susceptible organisms. Its broad-spectrum efficacy and well-established safety profile make it a cornerstone in empirical and directed antimicrobial therapy.
Features
- Chemical name: (2S,5R,6R)-6-([(2R)-2-Amino-2-phenylacetyl]amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
- Molecular formula: C₁₆H₁₉N₃O₄S
- Available forms: Oral capsules (250 mg, 500 mg), powder for oral suspension (125 mg/5 mL, 250 mg/5 mL), intravenous/intramuscular injection (250 mg, 500 mg, 1 g, 2 g vials)
- Mechanism: Inhibits transpeptidation step in bacterial cell wall synthesis
- Spectrum: Effective against Streptococcus spp., Listeria monocytogenes, Enterococcus faecalis, Haemophilus influenzae, Escherichia coli, Proteus mirabilis, Salmonella spp., Shigella spp.
- Pharmacokinetics: Oral bioavailability 40%; peak serum concentration within 1-2 hours; protein binding 15-25%; primarily renal excretion
Benefits
- Provides broad-spectrum coverage against common pathogenic bacteria
- Demonstrates bactericidal activity, ensuring rapid microbial eradication
- Exhibits good tissue penetration, including cerebrospinal fluid when meninges are inflamed
- Shows synergistic effects with beta-lactamase inhibitors for enhanced spectrum
- Available in multiple formulations allowing flexible administration routes
- Cost-effective compared to many newer broad-spectrum antibiotics
Common use
Ampicillin is clinically employed for treating infections caused by susceptible strains of microorganisms. Common indications include respiratory tract infections such as bronchitis and pneumonia caused by Streptococcus pneumoniae and Haemophilus influenzae. It is effective against genitourinary infections including cystitis, pyelonephritis, and prostatitis caused by Escherichia coli, Enterococcus faecalis, and Proteus mirabilis. The antibiotic is particularly valuable in treating gastrointestinal infections caused by Salmonella typhi, Salmonella paratyphi, and Shigella species. In pediatric and neonatal populations, ampicillin remains a first-line agent for empirical treatment of suspected bacterial meningitis, often combined with an aminoglycoside or third-generation cephalosporin. It is also used for surgical prophylaxis in gastrointestinal and genitourinary procedures and for treating septicemia and endocarditis caused by susceptible organisms.
Dosage and direction
Adult dosage: For mild to moderate infections, 250-500 mg orally every 6 hours. For severe infections, 1-2 g intravenously every 4-6 hours. Maximum daily dose should not exceed 14 g.
Pediatric dosage: 50-100 mg/kg/day in equally divided doses every 6 hours for oral administration. For intravenous administration, 100-200 mg/kg/day in divided doses every 6 hours. For meningitis, 200-400 mg/kg/day IV in divided doses every 6 hours.
Renal impairment adjustment: For creatinine clearance 10-50 mL/min, administer every 6-12 hours. For creatinine clearance <10 mL/min, administer every 12-24 hours.
Administration guidelines: Oral doses should be taken on an empty stomach (1 hour before or 2 hours after meals) for optimal absorption. Intravenous administration should be by slow injection over 3-5 minutes or by infusion over 15-30 minutes. Intramuscular injections should be administered deep into a large muscle mass.
Treatment duration typically ranges from 7 to 14 days depending on infection severity and clinical response. Complete the full course of therapy even if symptoms improve earlier to prevent development of resistance.
Precautions
Patients should be monitored for signs of hypersensitivity reactions, especially those with history of allergy to penicillins, cephalosporins, or other beta-lactam antibiotics. Regular assessment of renal, hepatic, and hematopoietic function is recommended during prolonged therapy. Superinfection with resistant organisms including fungi may occur; monitor for diarrhea and other signs of secondary infection. Use with caution in patients with mononucleosis due to increased risk of skin rash. Ampicillin may decrease the effectiveness of oral contraceptives; alternative contraceptive methods should be considered during therapy. In patients with renal impairment, dosage adjustment is necessary to prevent accumulation and potential neurotoxicity. Periodic evaluation of organ system function is advised during treatment courses exceeding two weeks.
Contraindications
Ampicillin is contraindicated in patients with known hypersensitivity to penicillins or other beta-lactam antibiotics. History of amoxicillin- or ampicillin-associated cholestatic jaundice/hepatic dysfunction constitutes an absolute contraindication. The drug should not be administered to patients with previous history of ampicillin-associated erythematous rashes. Concomitant use with bacteriostatic antibiotics such as tetracyclines or chloramphenicol is contraindicated due to potential antagonism. Patients with infectious mononucleosis should not receive ampicillin due to high incidence of maculopapular rash. Severe renal impairment without appropriate dosage adjustment represents a contraindication to standard dosing regimens.
Possible side effect
Common reactions (≥1%): Gastrointestinal disturbances including diarrhea, nausea, vomiting, epigastric distress; mucocutaneous candidiasis; skin rash (maculopapular or urticarial); transient elevation of liver enzymes.
Less common reactions (0.1-1%): Pseudomembranous colitis; black hairy tongue; glossitis; stomatitis; vaginitis; headache; fatigue; interstitial nephritis; eosinophilia.
Rare but serious reactions (<0.1%): Anaphylaxis; Stevens-Johnson syndrome; toxic epidermal necrolysis; hemolytic anemia; thrombocytopenia; leukopenia; neutropenia; agranulocytosis; hepatitis; cholestatic jaundice; seizures (especially with high doses in renal impairment); Clostridium difficile-associated diarrhea.
Laboratory abnormalities: Increased AST, ALT, alkaline phosphatase; positive Coombs test; false-positive urinary glucose tests with Benedict’s solution.
Drug interaction
Significant interactions: Probenecid decreases renal tubular secretion of ampicillin, increasing and prolonging serum levels. Concurrent use with allopurinol may increase incidence of skin rashes. Oral anticoagulants may have enhanced effects due to ampicillin’s impact on gut flora and vitamin K production. Ampicillin may reduce the efficacy of oral contraceptives. Bacteriostatic antibiotics (tetracyclines, chloramphenicol, sulfonamides) may antagonize ampicillin’s bactericidal effect.
Moderate interactions: Methotrexate clearance may be reduced, increasing toxicity risk. Aminoglycosides may be inactivated if mixed in the same solution with ampicillin. The drug may interfere with urinary glucose tests using copper reduction methods.
Management: Monitor patients for increased ampicillin effects when used with probenecid. Consider alternative contraception during therapy. Administer aminoglycosides separately from ampicillin. Monitor coagulation parameters when used with anticoagulants.
Missed dose
If a dose is missed, it should be taken as soon as remembered unless it is almost time for the next scheduled dose. In that case, skip the missed dose and resume the regular dosing schedule. Do not double the dose to make up for a missed administration. Maintaining consistent antibiotic levels is crucial for therapeutic efficacy and resistance prevention. If multiple doses are missed, contact the healthcare provider for guidance on regimen adjustment. Patients should be educated on the importance of adherence to the prescribed dosing schedule to ensure optimal treatment outcomes.
Overdose
Ampicillin overdose may manifest as neuromuscular hypersensitivity seizures, especially in patients with renal impairment. Gastrointestinal effects including nausea, vomiting, and diarrhea are common. Electrolyte imbalances may occur secondary to gastrointestinal losses.
Management: There is no specific antidote for ampicillin overdose. Treatment is supportive and symptomatic. Gastric lavage or activated charcoal may be considered if ingestion occurred within 2 hours. Maintain adequate hydration and electrolyte balance. Hemodialysis may be effective in removing ampicillin from the circulation, particularly in patients with renal impairment. Monitor renal function and neurological status closely. Seizures should be managed with standard anticonvulsant therapy. Contact poison control center for latest management recommendations.
Storage
Store capsules and powder for oral suspension at controlled room temperature (20-25°C or 68-77°F) in tightly closed containers. Protect from moisture and light. Reconstituted oral suspension is stable for 14 days at room temperature or under refrigeration; discard after this period. Powder for injection should be stored at room temperature. Reconstituted solutions for intravenous or intramuscular use should be used immediately; stability varies with diluent and concentration. Do not freeze any form of the medication. Keep out of reach of children. Do not use beyond the expiration date printed on the packaging.
Disclaimer
This information is provided for educational purposes only and does not constitute medical advice. The content is not intended to be a substitute for professional medical judgment, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or medication. Never disregard professional medical advice or delay in seeking it because of something you have read in this document. Healthcare professionals should verify dosage information and contraindications before prescribing. The manufacturer’s prescribing information should be consulted for complete details regarding administration, warnings, and precautions.
Reviews
Clinical efficacy: Systematic reviews and meta-analyses consistently demonstrate ampicillin’s effectiveness against susceptible organisms, with clinical cure rates exceeding 85% for common community-acquired infections. The drug remains particularly valuable for enterococcal infections and Listeria meningitis where it often represents first-line therapy.
Safety profile: Large-scale pharmacovigilance studies confirm the generally favorable safety profile of ampicillin, with most adverse effects being mild and reversible. Hypersensitivity reactions remain the most significant concern, occurring in approximately 5-10% of patients with penicillin allergy history.
Resistance patterns: Surveillance data indicate increasing resistance among Gram-negative organisms, particularly E. coli and H. influenzae, limiting empirical use in some regions. However, ampicillin maintains excellent activity against many Gram-positive organisms and remains a drug of choice for specific indications.
Comparative effectiveness: Studies comparing ampicillin with newer antibiotics show comparable efficacy for susceptible organisms, with the advantage of lower cost and extensive clinical experience. The drug’s synergy with beta-lactamase inhibitors addresses many resistance concerns while maintaining the favorable safety profile of the penicillin class.